Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation
ROCKVILLE, Md. and SUZHOU, China, Dec. 19, 2023 /PRNewswire/ — Innovent Biologics, Inc. ("Innovent") (HKEX:…